ESR1 and breast cancer: The bank closely resembles key features of the original tumors, such as ER/PR expression and mutational profiles (PIK3CA and TP53), offering an invaluable tool for investigating the molecular and cellular mechanisms that contribute to BC progression and drug resistance.